SH2B1 and type 2 diabetes mellitus: These results align with results obtained from the eQTLGen dataset and highlight SH2B1 as the best candidate gene for the increased T2D risk observed in deletion carriers, involving brain, adipose tissue, and muscle as plausible effector tissues.